3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Pain, Postoperative
4
Breast Neoplasms
4
Liver Neoplasms
2
Colonic Neoplasms
2
Chronic Pain
2
Carcinoma, Non-Small-Cell Lung
2
Supratentorial Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Recurrence
1
Prostatic Neoplasms
1
Postoperative Hemorrhage
1
Pilonidal Sinus
1
Pain
1
Oropharyngeal Neoplasms
1
Opioid-Related Disorders
1
Nevus, Pigmented
1
Neuroma
1
Neuralgia
1
Neoplasms
1
Melanoma
1
Malignant Pleural Neoplasm
1
Lung Neoplasms
1
Localised Prostate Cancer
1
Leiomyoma
1
Ileus
1
Hordeolum
1
Glioblastoma
1
Eyelid Neoplasms
1
Colorectal Neoplasms
1
Carcinoma, Squamous Cell
1
Interventions
pembrolizumab
25
Cisplatin
20
Carboplatin
14
Paclitaxel
11
Radiotherapy
9
Radiotherapy, Intensity-Modulated
8
Docetaxel
8
Cetuximab
8
Nivolumab
6
cemiplimab
5
Radiation
5
durvalumab
4
atezolizumab
3
Taxes
3
Surveys and Questionnaires
3
Fluorouracil
3
Drug Therapy
3
Cyclophosphamide
3
Blood Specimen Collection
3
toripalimab
2
olaparib
2
fludarabine
2
avelumab
2
alpha-2'-deoxythioguanosine
2
aldesleukin
2
Surgical Procedures, Operative
2
Standard of Care
2
Pemetrexed
2
Magnetic Resonance Spectroscopy
2
vistusertib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Carcinoma, Squamous Cell
×
Lidocaine
×
1 year
×
Clear all
NCT06747390
2026-05-12
856397
Abramson Cancer Center at Penn Medicine
Phase 1
Recruiting
30 enrolled